Core Strength Training on Anaerobic Power And Core Strength in Basketball Players

NCT05568771 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2023-03-21

No results posted yet for this study

Summary

The aim of the study is to investigate the effect of injury prevention program with core strength training support on anaerobic power and core strength in woman basketball Players In this direction, it is expected that the program will contribute to the decrease in the incidence of injury, the vertical jump distance, which is an indicator of anaerobic power, and the increase of core muscle strength.

Conditions

  • Sports Physical Therapy

Interventions

OTHER

Core Exercises Assisted Injury Prevention Training Program

After the exercises are fully taught to the athletes, the core training program will be applied on 3 non-consecutive days of the week, accompanied by a physiotherapist or athletic trainer, and the warm-up program will be applied before all trainings of the team, except before the match.The core program will take 20-25 minutes, and the warm-up program will take an average of 20-25 minutes. The exercises consist of an average of 45 minutes. This warm-up program includes running exercises, strengthening exercises, balance and proprioception exercises, and plyometric exercises.

Sponsors & Collaborators

  • Halic University

    lead OTHER

Principal Investigators

  • Bülent BAYRAKTAR, Prof · Istanbul University

  • Ömer Bayrak · Istanbul University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
24 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2022-12-20
Completion
2023-01-02

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05568771 on ClinicalTrials.gov